The Food and Drug Administration (FDA) has approved onabotulinumtoxin A for adult patients who suffer headaches on 15 or more days per month, lasting more than 4 hours. News, Medscape Medical News, October 2010

Leave a comment

* Copy This Password *

* Type Or Paste Password Here *

What is 10 + 5 ?
Please leave these two fields as-is:
IMPORTANT! To be able to proceed, you need to solve the following simple math (so we know that you are a human) :-)
Skip to toolbar